These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 23941044)

  • 1. Substituted tetrahydroisoquinolines as selective antagonists for the orexin 1 receptor.
    Perrey DA; German NA; Gilmour BP; Li JX; Harris DL; Thomas BF; Zhang Y
    J Med Chem; 2013 Sep; 56(17):6901-16. PubMed ID: 23941044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of 1-substitution on tetrahydroisoquinolines as selective antagonists for the orexin-1 receptor.
    Perrey DA; German NA; Decker AM; Thorn D; Li JX; Gilmour BP; Thomas BF; Harris DL; Runyon SP; Zhang Y
    ACS Chem Neurosci; 2015 Apr; 6(4):599-614. PubMed ID: 25643283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-acyl 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline: the first orexin-2 receptor selective non-peptidic antagonist.
    Hirose M; Egashira S; Goto Y; Hashihayata T; Ohtake N; Iwaasa H; Hata M; Fukami T; Kanatani A; Yamada K
    Bioorg Med Chem Lett; 2003 Dec; 13(24):4497-9. PubMed ID: 14643355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and Evaluation of Orexin-1 Receptor Antagonists with Improved Solubility and CNS Permeability.
    Perrey DA; Decker AM; Zhang Y
    ACS Chem Neurosci; 2018 Mar; 9(3):587-602. PubMed ID: 29129052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of dual orexin receptor antagonists (DORAs) for the treatment of insomnia.
    Coleman PJ; Cox CD; Roecker AJ
    Curr Top Med Chem; 2011; 11(6):696-725. PubMed ID: 21261591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The importance of the 6- and 7-positions of tetrahydroisoquinolines as selective antagonists for the orexin 1 receptor.
    Perrey DA; Decker AM; Li JX; Gilmour BP; Thomas BF; Harris DL; Runyon SP; Zhang Y
    Bioorg Med Chem; 2015 Sep; 23(17):5709-24. PubMed ID: 26216017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical and electrophysiological characterization of almorexant, a dual orexin 1 receptor (OX1)/orexin 2 receptor (OX2) antagonist: comparison with selective OX1 and OX2 antagonists.
    Malherbe P; Borroni E; Pinard E; Wettstein JG; Knoflach F
    Mol Pharmacol; 2009 Sep; 76(3):618-31. PubMed ID: 19542319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence that orexin-A-evoked grooming in the rat is mediated by orexin-1 (OX1) receptors, with downstream 5-HT2C receptor involvement.
    Duxon MS; Stretton J; Starr K; Jones DN; Holland V; Riley G; Jerman J; Brough S; Smart D; Johns A; Chan W; Porter RA; Upton N
    Psychopharmacology (Berl); 2001 Jan; 153(2):203-9. PubMed ID: 11205420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diaryl urea analogues of SB-334867 as orexin-1 receptor antagonists.
    Perrey DA; Gilmour BP; Runyon SP; Thomas BF; Zhang Y
    Bioorg Med Chem Lett; 2011 May; 21(10):2980-5. PubMed ID: 21478014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disubstituted piperidines as potent orexin (hypocretin) receptor antagonists.
    Jiang R; Song X; Bali P; Smith A; Bayona CR; Lin L; Cameron MD; McDonald PH; Kenny PJ; Kamenecka TM
    Bioorg Med Chem Lett; 2012 Jun; 22(12):3890-4. PubMed ID: 22617492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orexin receptors: pharmacology and therapeutic opportunities.
    Scammell TE; Winrow CJ
    Annu Rev Pharmacol Toxicol; 2011; 51():243-66. PubMed ID: 21034217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orexin-1 receptor antagonist SB-334867 reduces the acquisition and expression of cocaine-conditioned reinforcement and the expression of amphetamine-conditioned reward.
    Hutcheson DM; Quarta D; Halbout B; Rigal A; Valerio E; Heidbreder C
    Behav Pharmacol; 2011 Apr; 22(2):173-81. PubMed ID: 21285875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping the binding pocket of dual antagonist almorexant to human orexin 1 and orexin 2 receptors: comparison with the selective OX1 antagonist SB-674042 and the selective OX2 antagonist N-ethyl-2-[(6-methoxy-pyridin-3-yl)-(toluene-2-sulfonyl)-amino]-N-pyridin-3-ylmethyl-acetamide (EMPA).
    Malherbe P; Roche O; Marcuz A; Kratzeisen C; Wettstein JG; Bissantz C
    Mol Pharmacol; 2010 Jul; 78(1):81-93. PubMed ID: 20404073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of orexin 1 receptors in the periaqueductal gray of male rats leads to antinociception via retrograde endocannabinoid (2-arachidonoylglycerol)-induced disinhibition.
    Ho YC; Lee HJ; Tung LW; Liao YY; Fu SY; Teng SF; Liao HT; Mackie K; Chiou LC
    J Neurosci; 2011 Oct; 31(41):14600-10. PubMed ID: 21994376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orexins modulate the growth of cultured rat adrenocortical cells, acting through type 1 and type 2 receptors coupled to the MAPK p42/p44- and p38-dependent cascades.
    Spinazzi R; Ziolkowska A; Neri G; Nowak M; Rebuffat P; Nussdorfer GG; Andreis PG; Malendowicz LK
    Int J Mol Med; 2005 May; 15(5):847-52. PubMed ID: 15806308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemical stimulation of the lateral hypothalamus induces conditioned place preference in rats: Involvement of OX1 and CB1 receptors in the ventral tegmental area.
    Taslimi Z; Haghparast A; Hassanpour-Ezatti M; Safari MS
    Behav Brain Res; 2011 Feb; 217(1):41-6. PubMed ID: 20937330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orexin-mediated restoration of hippocampal synaptic potentiation in mice with established cocaine-conditioned place preference.
    Lu GL; Lee MT; Chiou LC
    Addict Biol; 2019 Nov; 24(6):1153-1166. PubMed ID: 30276922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional and binding kinetic studies make a distinction between OX1 and OX2 orexin receptor antagonists.
    Faedo S; Perdonà E; Antolini M; di Fabio R; Merlo Pich E; Corsi M
    Eur J Pharmacol; 2012 Oct; 692(1-3):1-9. PubMed ID: 22796453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of orexin-1 receptors attenuates orexin-2 receptor antagonism-induced sleep promotion in the rat.
    Dugovic C; Shelton JE; Aluisio LE; Fraser IC; Jiang X; Sutton SW; Bonaventure P; Yun S; Li X; Lord B; Dvorak CA; Carruthers NI; Lovenberg TW
    J Pharmacol Exp Ther; 2009 Jul; 330(1):142-51. PubMed ID: 19363060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery, synthesis, selectivity modulation and DMPK characterization of 5-azaspiro[2.4]heptanes as potent orexin receptor antagonists.
    Stasi LP; Artusi R; Bovino C; Buzzi B; Canciani L; Caselli G; Colace F; Garofalo P; Giambuzzi S; Larger P; Letari O; Mandelli S; Perugini L; Pucci S; Salvi M; Toro P
    Bioorg Med Chem Lett; 2013 May; 23(9):2653-8. PubMed ID: 23535328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.